New Hope for Patients with Metastatic Triple-Negative Breast Cancer: Antibody Drug Conjugate Doubles Survival Time for Some Patients

Published Apr 23, 2021

New Hope for Patients with Metastatic Triple-Negative Breast Cancer: Antibody Drug Conjugate Doubles Survival Time for Some Patients

NOW
PLAYING
Shannen Doherty Shows the Down Days of Cancer During Breast Cancer Awareness Month; How to Combat the Effects of Treatment
NOW
PLAYING
Cancer Trials Have Room to Improve, New Data Show
NOW
PLAYING
James Marsden Praises Co-Star and Multiple Sclerosis Patient Christina Applegate
NOW
PLAYING
ENHERTU Is A 'Big Game Changer' for HER2 Positive Metastatic Breast Cancer Patients
NOW
PLAYING
New Hope for Patients With Cervical Cancer: Adding Immunotherapy Drug to Standard Chemo Treatment Could Improve Survival Time
NOW
PLAYING
Cancer Survivor Rita Wilson Raps at Emmy's

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.